Lactam derivatives as antagonists for human 11cby receptors

Details Lactam derivatives as antagonists for human 11cby receptors Lactam derivatives as antagonists for human 11cby receptors

2007-05-22

2007-05-22

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S423000, C548S566000, C548S567000

Reexamination Certificate

active

10492062

ABSTRACT:
The invention provides compounds of formula (I)a salt, or solvate thereof.

REFERENCES:
patent: WO 97/41097 (1997-11-01), None
patent: WO 01/21577 (2001-03-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al., Advanced Drug Delivery Reviews 48; 3-26, 2001.
Mashiko et al., Endocrinology 146(7): 3080-3086, 2005.
Saxena S et al.,Anti-Inflammatory Quinazolinoes, Indian Journal of Pharmaceutical Sciences 53(2): 48-52 (Mar. 1991).
Database Caplus Online, Chemical Abstrats Service, Coloumbus Ohio, US, Database accession No. 1991:122049 XP002233183 abstract & PL 137 227 B (Uniwersytel Lodzki, Lodz (Polska) Mar. 31, 1987 table.

Affiliated with

Also associated with

Rating

Lactam derivatives as antagonists for human 11cby receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lactam derivatives as antagonists for human 11cby receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactam derivatives as antagonists for human 11cby receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3778950